Quality Medicines Diseases Newsroom Feed back Contact us

Non-Hodgkin's Lymphoma Button

Health Care
Diseases and Indications
Non-Hodgkin's Lymphoma

Non-Hodgkin's lymphoma (NHL) is a cancer that develops in lymphatic tissue, which is found in many places throughout the body, including the lymph nodes, spleen, thymus gland, adenoids, tonsils and bone marrow. Approximately 1.5 million people world-wide currently live with NHL and each year an estimated 300,000 people die from this disease. The incidence is rising 3-7 percent per year, making it the second fastest-growing cancer in the United States and the third fastest-growing in the rest of the world. It occurs mainly in adults, most frequently in people between 45 and 60 years of age.

What is NHL?
The lymphatic system, an important part of the immune system, plays a major role in the body's defence against infection. While non-Hodgkin's Lymphoma (NHL) starts in the lymphatic tissue, it can spread to other organs.

NHL is generally classified into two equal groups:

  • Aggressive (intermediate/high grade) NHL is characterised by rapidly dividing cancer cells of the lymph node region, and requires immediate treatment. Without successful treatment, the average life expectancy of patients with aggressive NHL is six months to two years. Patients who are diagnosed and treated in the early stages of aggressive disease are more likely to experience a complete remission of several years' duration and are less likely to have late recurrences.

  • Indolent lymphomas slowly divide and multiply in the body making initial diagnosis more difficult. Patients may live an average of 10 years with the disease and an average patient with indolent NHL can expect to be treated five to six times over their life span in order to slow the disease progression. Standard treatments cannot cure indolent disease.

Conventional Therapy
Treatment of NHL depends on the type of tumour and how advanced it is. Current treatments include 'watch and wait' until the cancer causes symptoms, chemotherapy, monoclonal antibody therapy, radiation, biological treatments and bone marrow transplantation. In patients with aggressive NHL, standard chemotherapy is successful in three to four people out of 10.

Flying High

Doctor Observing
Germs Look
Baby Sleeping


Gelatin Capsules

  Company   Products   Diseases   Health   Media   R & D   Sustainability  
  Figure & Reports   Investors   Countries   E-mail us      Divisions   Contact us   Home  

         Copyright 2005 TAJ Pharmaceuticals Limited ,434 LAXMI PLAZA (LAXMI INDUSTRIAL ESTATE) NEW LINK ROAD Andheri (W) MUMBAI-53. INDIA

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

| Privacy Policy | Terms & Conditions | Sitemap |